Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between the ages of 20 and 70
- People who have been assessed by an anaesthesiologist as being in generally good to mild-risk health (classified as ASA I or II — confirm with trial site if unsure what this means)
- People with a body mass index (BMI) between 18 and 26 kg/m²
- People who are willing and able to sign a consent form agreeing to take part in the study
Who may not be able to join:
- People the researchers consider unsuitable for receiving medication through a nasal spray, such as those with severe hay fever-type nasal conditions or nasal structural problems
- People with a very slow heart rate (fewer than 50 beats per minute) or a history of heart rhythm conduction problems
- People with a history of upper respiratory tract infections (such as infections affecting the nose, throat, or airways)
- People with a history of asthma
- People with a known allergy to DEX (dexmedetomidine) or local anaesthetic medicines
- People who have taken anti-anxiety medication before the operation
- People with a history of stroke or mini-strokes (transient ischemic attacks)
- People whose blood pressure is not well controlled, even with medication
- People with a history of mental illness, memory or thinking difficulties, or epilepsy
- People with a history of pregnancy
- People who have been regularly taking sedatives or pain relief medicines over a long period
- People with a history of liver or kidney problems
- People with a history of drug or alcohol misuse
- People the trial reviewers consider unsuitable for other reasons, such as concerns about whether they would be able to follow the trial's procedures
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 158 2294 6764
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Observer's Assessment of Alterness/Sedation and Numerical rating scale; Hospital Anxiety and Depression Scale (HADS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.